Biogen's Singhal On Stepping Into R&D Leadership Shoes Amid Aduhelm Controversy

 
• By Jessica Merrill
Priya Singhal
Biogen interim head of RYD Priya Singhal • Source: Pharma Intelligence / Biogen

More from Leadership

More from Scrip